Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels

PLoS Computational Biology

Volumn 13, Issue 1, 2017, Pages

  Doekes, Hilje M ^a,b   Fraser, Christophe ^a,c   Lythgoe, Katrina A ^a,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DYNAMICS;

CD4 T-CELLS; CELL-BE; CELL/B.E; CELL/BE; EPIDEMIOLOGICAL MODELING; EVOLUTIONARY DYNAMICS; HIV DYNAMICS; LONG DELAYS; QUASISPECIES MODEL; VIRAL LOAD;

VIRUSES;

ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; EVOLUTION; HOST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PREDICTION; VIRUS ACTIVATION; VIRUS CARRIER; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; BIOLOGICAL MODEL; BIOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS LATENCY;

BIOLOGICAL EVOLUTION; CD4-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; VIRUS LATENCY;

EID: 85011349933     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1005228     Document Type: Article

References (74)

1. Chun T., Carruth L., Finzi D., Shen X., DiGiuseppe J. A., Taylor H., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997; 387(6629): 183–188. doi: 10.1038/387183a09144289
2. Finzi D., Hermankova M., Pierson T., Carruth L. M., Buck C., Chaisson R. E., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997; 278(5341): 1295–1300. 9360927
3. Chun T., Engel D., Berrey M. M., Shea T., Corey L., Fauci A. S., Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection. Proc Natl Acad Sci USA. 1998; 95(15): 8869–8873. 9671771
4. Whitney J., Hill A., Sanisetty S., Penaloza-Macmaster P., Liu J., Shetty M., et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature. 2014; 512(1): 74–77.
5. Siliciano J. D., Kajdas J., Finzi D., Quinn T. C., Chadwick K., Margolick J. B., et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T cells. Nat Med. 2003; 9(6): 727–728. doi: 10.1038/nm88012754504
6. Chun T., Engel D., Mizell S., Ehler L., Fauci A., Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med. 1998; 188(1): 83 91. 9653086
7. Chun T., Fauci A. S., HIV reservoirs: Pathogenesis and obstacles to viral eradication and cure. AIDS. 2012; 26(10): 1261–1268. doi: 10.1097/QAD.0b013e328353f3f122472858
8. Eisele E., Siliciano R., Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity. 2012; 37(3): 377–388. doi: 10.1016/j.immuni.2012.08.01022999944
9. Alizon S., Magnus C., Modelling the course of an HIV infection: Insights from ecology and evolution. Viruses. 2012; 4(10): 1984–2013. doi: 10.3390/v410198423202449
10. Perelson A. S., Ribeiro R. M., Modeling the within-host dynamics of HIV infection. BMC Biol. 2013; 11(96).
11. Kelly J., Replication rate and evolution of the Human Immunodeficiency Virus. J Theor Biol. 1996; 180: 359–364. doi: 10.1006/jtbi.1996.01088776467
12. Kelly J., Williamson S., Orive M., Smith M., Holt R., Linking dynamical and population genetic models of persistent viral infection. Am Nat. 2003; 162(1): 14–28. doi: 10.1086/37554312856234
13. Ward Z., White J., Impact of latently infected cells on strain archiving within HIV hosts. B Math Biol. 2012; 74(9): 1985–2003.
14. Immonen T., Leitner T., Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages. Retrovirology. 2014; 11(1), 81.
15. Immonen T., Conway J.M., Romero-Severson E.O., Perelson A.S., Leitner T., Recombination enhances HIV-1 envelope diversity by facilitating the survival of latent genomic fragments in the plasma virus population. PLoS Comp Biol. 2015; 11(12): e1004625.
16. Pybus O. G., Rambaut A., Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet. 2009; 10(8): 540–550. doi: 10.1038/nrg258319564871
17. Lythgoe K. A., Fraser C., New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels. Proc R Soc B. 2012; 279(1741): 3367–3375. doi: 10.1098/rspb.2012.059522593106
18. Alizon S., Fraser C., Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology. 2013; 10(1).
19. Vrancken B., Rambaut A., Suchard M. A., Drummond A., Baele G., Derdelinckx I., et al. The genealogical population dynamics of HIV-1 in a large transmission chain: Bridging within and among host evolutionary rates. PLoS Comp Biol. 2014; 10(4).
20. Lythgoe K. A., Pellis L., Fraser C., Is HIV short-sighted? Insights from a multistrain nested model. Evolution. 2013; 67(10): 2769–2782. doi: 10.1111/evo.1216624094332
21. Fraser C., Lythgoe K., Leventhal G. E., Shirreff G., Hollingsworth T. D., Alizon S., Bonhoeffer S., Virulence and pathogenesis of HIV-1 infection: An evolutionary perspective. Science. 2014; 343(6177): 1243727-1-6.
22. Ibáñez A., Puig T., Elias J., Clotet B., Ruiz L., Martínez M., Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. AIDS. 1999; 13(9): 1045–1049. 10397534
23. Andreoni M., Parisi S. G., Sarmati L., Nicastri E., Ercoli L., Mancino G., et al. Cellular proviral HIV-DNA decline and viral isolation in naive subjects with 500 x 106/l CD4 cells treated with highly active antiretroviral therapy. AIDS. 2000; 14(1): 23–29. 10714564
24. Ngo-Giang-Huong N., Deveau C., Da Silva I., Pellegrin I., Venet A., Harzic M., et al. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy. AIDS. 2001; 15(6): 665–673. 11371680
25. Koelsch K. K., Liu L., Haubrich R., May S., Havlir D., Günthard H. F., et al. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008; 197(3): 411–419. doi: 10.1086/52528318248304
26. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F. A., Yassine-Diab B., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8): 893–900. doi: 10.1038/nm.197219543283
27. Troyer R. M., Collins K. R., Abraha A., Fraundorf E., Moore D. M., Krizan R. W., Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J Virol. 2005; 79(14): 9006–9018. doi: 10.1128/JVI.79.14.9006-9018.200515994794
28. Kouyos R., von Wyl V., Hinkley T., Petropoulos C., Haddad M., Whitcomb J., et al. Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathog. 2011; 7(11): e1002321. doi: 10.1371/journal.ppat.100232122072960
29. Quinones-Mateu M., Ball S., Marozsan A., Torre V., Albright J., Vanham G., et al. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol. 2000; 74(19): 9222–9233. 10982369
30. Prince J. L., Claiborne D. T., Carlson J. M., Schaefer M., Yu T., Lahki S., et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog. 2012; 8(11): e1003041. doi: 10.1371/journal.ppat.100304123209412
31. Mellors J., Rinaldo C., Gupta P., White R., Todd J., Kingsley L., Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996; 272: 1167–1170. 8638160
32. de Wolf F., Spijkerman I., Schellekens P., Langendam M., Kuiken C., Bakker M., et al. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion. AIDS. 1997; 11(15): 1799–1806. 9412697
33. Quinn T., Wawer M., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000; 342(13): 921–929. doi: 10.1056/NEJM20000330342130310738050
34. Lingappa J., Hughes J., Wang R., Baeten J., Celum C., Gray G., et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS ONE. 2010; 5(9): e12598. doi: 10.1371/journal.pone.001259820856886
35. Fraser C., Hollingsworth T. D., Chapman R., De Wolf F., Hanage W. P., Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci USA. 2007; 104(44): 17441–17446. doi: 10.1073/pnas.070855910417954909
36. Blanquart F., Grabowski M.K., Herbeck J., Nalugoda F., Serwadda D., Eller M.A., et al. A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. eLife. 2016; 5: e20492. doi: 10.7554/eLife.2049227815945
37. Shirreff G., Pellis L., Laeyendecker O., Fraser C., Transmission selects for HIV-1 strains of intermediate virulence: A modelling approach. PLoS Comp Biol. 2011; 7(10).
38. Levin B. R., Bull J. J., Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol. 1994; 2(3): 76–81. 8156275
39. van Dorp C.H., van Boven M., de Boer R.J., Immuno-epidemiological modeling of HIV-1 predicts high heritability of the set-point virus load, while selection for CTL escape dominates virulence evolution. PLoS Comp Biol. 2014; 10(12): e1003899.
40. Eigen M., Selforganization of matter and the evolution of biological macromolecules. Die Naturwissenschaften. 1971; 58(10): 465–523. 4942363
41. Lythgoe K. A., Blanquart F., Pellis L., Fraser C., Large variations in HIV-1 viral load explained by shifting-mosaic metapopulation dynamics. PLoS Biol. 2016; 14(10): e1002567. doi: 10.1371/journal.pbio.100256727706164
42. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D., HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science. 1996; 271(5255): 1582–1586. 8599114
43. Mansky L., Temin H., Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995; 69(8): 5087–5094. 7541846
44. Gao F., Chen Y., Levy D., Conway J., Kepler T., Hui H., Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol. 2004; 78(5): 2426–2433. doi: 10.1128/JVI.78.5.2426-2433.200414963138
45. Keele B. F., Giorgi E. E., Salazar-Gonzalez J. F., Decker J. M., Pham K. T., Salazar M. G., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA. 2008; 105(21): 7552–7557. doi: 10.1073/pnas.080220310518490657
46. Abrahams M.-R., Anderson J.A., Giorgi E.E., Seoighe C., Mlisana K., Ping L.-H., et al. Quantitating the multiplicity of infection with human immunodeficiency virus type I subtype C reveals a non-Poisson distribution of transmitted variants. J Virol. 2009; 83(8): 3556–3567. doi: 10.1128/JVI.02132-0819193811
47. Tully D.C., Ogilvie C.B., Batorsky R.E., Bean D.J., Power K.A., Ghebremichael M., et al. Differences in the selection bottleneck between modes of sexual transmission influence the genetic composition of the HIV-1 founder virus. PLoS Pathog. 2016; 12(5): e1005619. doi: 10.1371/journal.ppat.100561927163788
48. Zanini F., Brodin J., Thebo L., Lanz C., Bratt G., Albert J., Neher R.A., Population genomics of intrapatient HIV-1 evolution. eLife. 2015; 4: e11282. doi: 10.7554/eLife.1128226652000
49. Diekmann O., Heesterbeek J. A. P., Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. Wiley, Oxford, UK; 2000.
50. Mideo N., Alizon S., Day T., Linking within- and between-host dynamics in the evolutionary epidemiology of infectious diseases. Trends Ecol Evol. 2008; 23(9): 511–517. doi: 10.1016/j.tree.2008.05.00918657880
51. Redd A. D., Collinson-Streng A. N., Chatziandreou N., Mullis C. E., Laeyendecker O., Martens C., et al. Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J Infect Dis. 2012; 206(9): 1433–1442. doi: 10.1093/infdis/jis50322997233
52. Deymier M. J., Ende Z., Fenton-May A. E., Dilerna D. A., Kilembe W., Allen S. A., et al. Heterosexual transmission of subtype C HIV-1 selects consensus-like variants without increased replicative capacity or interferon-α resistance. PLoS Pathog. 2015; 11(9): e1005154. doi: 10.1371/journal.ppat.100515426378795
53. Carlson J.M., Schaefer M., Monaco D.C., Batorsky R., Claiborne D.T., Prince J., et al. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science. 2014; 345(6193): 1254031-1-12.
54. Sedaghat A. R., Rastegar D. A., OConnell K. A., Dinoso J. B., Wilke C. O., Blankson J. N., T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clin Infect Dis. 2009; 49(11): 1763–1766. doi: 10.1086/64808119857162
55. Mens H., Kearney M., Wiegand A., Shao W., Schnning K., Gerstoft J., et al. HIV-1 continues to replicate and evolve in patients with natural control of HIV infection. J Virol. 2010; 84(24): 12971–12981. doi: 10.1128/JVI.00387-1020926564
56. Hatano H., Yukl S. A., Ferre A. L., Graf E. H., Somsouk M., Sinclair E., et al. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013; 9(10): e1003691. doi: 10.1371/journal.ppat.100369124130489
57. Lemey P., Kosakovsky Pond S. L., Drummond A. J., Pybus O. G., Shapiro B., Barroso H., et al. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comp Biol. 2007; 3(2): 0282–0292.
58. Cuevas J. M., Geller G., Garijo R., López-Aldeguer J., Sanjuán R., Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 2015; 13(9): e1002251. doi: 10.1371/journal.pbio.100225126375597
59. Eriksson S., Graf E. H., Dahl V., Strain M. C., Yukl S. A., Lysenko E. S., et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013; 9(2).
60. Ho Y., Shan L., Hosmane N. N., Wang J., Laskey S. B., Rosenbloom D. I. S., et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 2013; 155(3): 540–551. doi: 10.1016/j.cell.2013.09.02024243014
61. Kim H., Perelson A. S., Viral and latent reservoir persistence in HIV-1-infected patients on therapy. PLoS Comp Biol. 2006; 2(10): 1232–1247.
62. Rong L., Perelson A. S., Modeling latently infected cell activation: Viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy. PLoS Comp Biol. 2009; 5(10).
63. Maldarelli F., Wu X., Su L., Simonetti F., Shao W., Hill S., et al. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 2014; 345(6193): 179–183. doi: 10.1126/science.125419424968937
64. Wagner T. A., McLaughlin S., Garg K., Cheung C. Y., Larsen B. B., Styrchak S., et al. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science. 2014; 345(6196): 570–573. doi: 10.1126/science.125630425011556
65. Cohn L. B., Silva I. T., Oliveira T. Y., Rosales R. A., Parrish E. H., et al. HIV-1 integration landscape during latent and active infection. Cell. 2015; 160: 420–432. doi: 10.1016/j.cell.2015.01.02025635456
66. Ganusov V. V., Goonetilleke N., Liu M. K. P., Ferrari G., Shaw G. M., McMichael A. J., et al. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J Virol. 2011; 85(20): 10518–10528. doi: 10.1128/JVI.00655-1121835793
67. Herbeck J. T., Rolland M., Liu Y., McLaughlin S., McNevin J., Zhao H., et al. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol. 2011; 85(15): 7523–7534. doi: 10.1128/JVI.02697-1021593162
68. Malderelli F., Kearney M., Palmer S., Stephens R., Mican J. A., Polis M. A., et al. HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. JVI. 2013; 87(18): 10313–10323.
69. Asquith B., Edwards C.T.T., Lipsitch M., McLean A.R., Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 2006; 4(4): e90. doi: 10.1371/journal.pbio.004009016515366
70. Roberts H. E., Hurst J., Robinson N., Brown H., Flanagan P., Vass L., et al. Structured observations reveal slow HIV-1 CTL escape. PLoS Genet. 2015; 11(2): e1004914. doi: 10.1371/journal.pgen.100491425642847
71. Jetzt A.E., Yu H., Klarmann G.J., Ron Y., Preston B.D., Dougherty J.P., High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol. 2000; 74(3): 1234–1240. 10627533
72. Schlub T.E., Smyth R.P., Grimm A.J., Mak J., Davenport M.P., Accurately measuring recombination between closely related HIV-1 genomes. PLoS Comp Biol. 2010; 6(4): e1000766.
73. de Boer R. J., Perelson A. S., Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol. 1998; 190: 201–214. doi: 10.1006/jtbi.1997.05489514649
74. Ribeiro R. M., Qin L., Chavez L. L., Li D., Self S. G., Perelson A. S., Estimation of the initial viral growth rate and basic reproduction number during acute HIV-1 infection. J Virol. 2010; 84(12): 6096–6102. doi: 10.1128/JVI.00127-1020357090